MOTS-c Peptide Stacking: Comparison
Before designing a research stack, it's essential to understand how MOTS-c interacts with different peptide classes. And which combinations offer synergistic benefits versus redundant signaling. Growth Hormone Secretagogues Ipamorelin, CJC-1295, GHRP-2 Stimula
This comparison does not assign a generated winner or score.
- Before designing a research stack, it's essential to understand how MOTS-c interacts with different peptide classes. And which combinations offer synergistic benefits versus redundant signaling.
- Growth Hormone Secretagogues
- Ipamorelin, CJC-1295, GHRP-2
- Stimulate pituitary GH release via ghrelin receptor agonism
- High. GH mobilizes fat, MOTS-c oxidizes it; independent pathways
- Separate by 30–60 min if both are short-acting; MOTS-c AM, GH secretagogues PM
- Excellent stack for body composition research
- Tissue Repair Peptides
- BPC-157, TB-500
- Promote angiogenesis, collagen synthesis, cell migration
- Moderate. MOTS-c supports ATP availability for repair processes
- No separation required; can dose together
- Effective for injury recovery models
- GLP-1/GIP Agonists
- Tirzepatide, Semaglutide
- Slow gastric emptying, enhance insulin secretion, reduce appetite
- Moderate. Both improve insulin sensitivity through different mechanisms
- No separation required due to tirzepatide's long half-life
- Potent metabolic stack but overlapping insulin effects require monitoring
- Lipolytic Peptides
- AOD9604
- Stimulate lipolysis without GH or IGF-1 elevation
- High. AOD releases fatty acids, MOTS-c oxidizes them
- No separation required; complementary fat metabolism pathways
- Strong synergy for fat loss research
- Longevity Peptides
- Epithalon, FOXO4-DRI
- Activate telomerase, clear senescent cells
- Low-Moderate. Independent anti-aging mechanisms
- No separation required; different cellular targets
- Viable stack for aging research but effects are additive, not synergistic
- Immune Modulators
- Thymosin Alpha 1, Thymalin
- Enhance T-cell function, regulate cytokine production
- Low. No direct metabolic interaction
- No separation required
- Compatible but serve different research endpoints